top of page

CAELYX CONCENTRATE FOR INFUSION 2 mg/ml

Product details

Registration number: SIN10426P

Classification: Prescription Only

Active ingredients: Doxorubicin Hydrochloride

Strength: 2.00 mg/ml

Dosage form: INJECTION

Route: INTRAVENOUS

Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD

ATC code: L01DB01

HSA approval date: 16 November 1998

Manufacturer(s):

  • Glaxosmithkline Manufacturing S.p.A. (Parma, Italy)
  • Simtra Deutschland GmbH

Manufacturing country/countries: ITALY; GERMANY

What are the HSA registration number and classification for CAELYX CONCENTRATE FOR INFUSION 2 mg/ml?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN10426P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for CAELYX CONCENTRATE FOR INFUSION 2 mg/ml?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Doxorubicin Hydrochloride

Strength: 2.00 mg/ml

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for CAELYX CONCENTRATE FOR INFUSION 2 mg/ml?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for CAELYX CONCENTRATE FOR INFUSION 2 mg/ml?

According to the HSA dataset updated 7 August 2026:

Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD

Source for this answer

Which manufacturers and countries are listed for CAELYX CONCENTRATE FOR INFUSION 2 mg/ml?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • Glaxosmithkline Manufacturing S.p.A. (Parma, Italy)
  • Simtra Deutschland GmbH

Manufacturing country/countries: ITALY; GERMANY

Source for this answer

Where can I look up CAELYX CONCENTRATE FOR INFUSION 2 mg/ml in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN10426P or the exact product name CAELYX CONCENTRATE FOR INFUSION 2 mg/ml. The general register link does not preselect this product.

Source for this answer

What are the source dates for this CAELYX CONCENTRATE FOR INFUSION 2 mg/ml record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this CAELYX CONCENTRATE FOR INFUSION 2 mg/ml record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN10426P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page